This study is currently not recruiting participants.
A Phase 3 Multicenter Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study.
The purpose of this study is to evaluate the long term safety and efficacy of RPC1063 in patients with moderately to severely active ulcerative colitis.
Detailed description of study
The purpose of this study is to evaluate the long term safety and efficacy of RPC1063 in patients with moderately to severely active ulcerative colitis.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:ulcerative colitis
Age:
100 years or below
Gender: All
Updated on
19 Jan 2016.
Study ID: 1511851648
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
